Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 542

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 542
---
 be loaned immediately, and an additional $0.2 million would be loaned within a month from the date of the loan agreement. The Prophase Loan bears no interest and is payable by the first anniversary of the month of the loan agreement. The Company repaid the $0.1 million on September 12, 2023. On December 11, 2023, the Company borrowed an additional $0.2 million from Prophase. The loan bears no interest and was due on or before December 21, 2024 or upon failure to close the Iris Business Combination. The Company repaid the $0.2 million on December 21, 2023. As of December 31, 2023 and 2022, the balance of the Prophase loans was $0. For the years ended December 31, 2023 and 2022, no interest expense was recorded related to the Prophase Loans.

Due to Related Party

As of December 31, 2023 and 2022, the Company had $0.2 million due to the CEO of the Company for compensation under his employment agreement for both years.

<div align='center'>F-82</div>

TABLE OF CONTENTS

LIMINATUS PHARMA, LLC NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022 Viral Gene As of December 31, 2023 and 2022, the Company has $0.1 million due from Viral Gene included in due from related party in the balance sheets for a short-term loan to Viral Gene and expense paid on behalf of Viral Gene. The Company’s CEO is also the CEO of Viral Gene. The loan does not bear any interest and imputed interest would be immaterial. Note 5. Debt The Company has the following debt outstanding as of December 31, 2023 and 2022 (in thousands):

| ​                                
 ​                                | ​ 
 ​ | ​ 
 ​ | ​                                     
 ​                                     | ​ 
 ​ | ​ 
 ​ | December 31, 
 2023         |   |        |   | ​ | ​ | 2022 |   |        |   | ​ 
 ​ |
|:---------------------------------|:--|:--|:--------------------------------------|:--|:--|:-------------|:--|-------:|:--|:--|:--|:-----|:--|-------:|:--|